Cirrus studies formulation effects on MDI performance for US FDA
Cirrus Pharmaceuticals has received a grant to investigate the effect of excipient concentration and API molecule size on metered dose inhaler (MDI) formulations.
Archives for October 16, 2013
Charles River expands presence in Asia with acquisition
Early stage drug developer Charles River Laboratories is pushing further into Asia with its purchase of the microbiology subcontractor BRASS Pte Ltd. Terms of the acquisition were not disclosed.
Jubilant eyes manufacturing expansions in US, India
CMO Jubilant LifeSciences is expanding at least four of its five manufacturing plants in the US and India as growth continues.
update
US and French regulators OK restart of LentiVector delivered eye drug trials
US and French regulators have given Oxford BioMedica the go ahead to restart studies of three eye drugs it is developing with Sanofi after an impurity found in trial materials was identified as a harmless culture media derivative.
Protein Sciences' efforts to expand approval for Flublok slowed by Shutdown
The US Government Shutdown has delayed the regulatory review of a new egg-free influenza vaccine production process developed by Protein Sciences.
Pennsylvania CRO expands EU reach with acquisition
CRO Clinlogix has expanded its reach in Europe with the acquisition of German CRO ikfe CRO GmbH.
DPT fielding calls from Ben Venue customers
US contractor DPT says it has received calls from customers of soon-to-close CMO Ben Venue Labs.